MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0001376
Byrl Bioceuticals India Private Limited
Byrl Bioceuticals India Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹19.96 Lakh
▲ 1143% YoY
Net loss · FY 2023
₹5.98 Lakh
Net margin -30%
EBITDA · FY 2023
-₹5.98 Lakh
EBITDA margin -30%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered
About Byrl Bioceuticals India Private Limited
Data last updated:
Byrl Bioceuticals India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 13 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U15400DL2020PTC367927. Its GSTIN is 07AAHCN0898H1Z4 (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It was formerly known as Neuhope Bioceuticals Private Limited. It is led by directors including Priyata Goyal and Akanksha Jain.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 702 7th Floor Madhuban Building 55, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2023, the company reported a revenue of ₹19.96 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.98 Lakh (net margin -30%) and EBITDA of -₹5.98 Lakh (EBITDA margin -30%).
Byrl Bioceuticals India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0001376).
Company details
CIN U15400DL2020PTC367927
Registration Number 367927
Incorporation Date 13 August 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0001376
Recognitions & Rankings of Byrl Bioceuticals India
Contact details
Byrl Bioceuticals India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address702 7th Floor Madhuban Building 55, New Delhi, Delhi, India – 110019
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Byrl Bioceuticals India Private Limited, buy the company report.
Comprehensive company report
Byrl Bioceuticals India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Byrl Bioceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Byrl Bioceuticals India Private Limited, buy the company report.
Financials of Byrl Bioceuticals India Private Limited
FY 2023 filings availableByrl Bioceuticals India Private Limited reported revenue of ₹19.96 Lakh (up 1143% YoY) for FY 2023.
Revenue · FY 2023
₹19.96 Lakh ▲ 1143%
Net loss · FY 2023
₹5.98 Lakh margin -30%
EBITDA · FY 2023
-₹5.98 Lakh margin -30%
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹19.96 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹5.98 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹5.98 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -30% | ||
| Net Profit Margin | -30% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Byrl Bioceuticals India Private Limited, buy the company report.
Board of directors of Byrl Bioceuticals India Private Limited
Byrl Bioceuticals India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akanksha Jain Also directs: Byrl Medical India Private Limited | Additional Director | 02 Jun 2021 | 5 Years 5 Months | Current |
| Ankur Goyal | Additional Director | 15 Jun 2022 | 4 Years 4 Months | Current |
| Priyata Goyal | Director | 13 Aug 2020 | 6 Years 3 Months | Current |
Peer comparison
Byrl Bioceuticals India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mechxon Lifecare Private Limited | ₹20.14 Lakh (FY 2024) | -5.0% | Bhopal, Madhya Pradesh, India | |||
| Clear Imaging Medical Systems Private Limited | ₹20.06 Lakh (FY 2024) | -61.0% | Bhopal, Madhya Pradesh, India | |||
| Byrl Bioceuticals India Private Limitedthis company | ₹19.96 Lakh (FY 2023) | -₹5.98 Lakh | -30% | 1143.0% | New Delhi, Delhi, India | |
| Gainwell Medimart Private Limited | ₹19.86 Lakh (FY 2025) | Bangalore, Karnataka, India |
To see the full peer comparison of Byrl Bioceuticals India Private Limited, buy the company report.
Auditor
Byrl Bioceuticals India Private Limited is audited by KRISHNANAND JHA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNANAND JHA AND ASSOCIATES | FY 2023 | 0025182N |
Shareholding
The shareholding of Byrl Bioceuticals India Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Byrl Bioceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Byrl Bioceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Byrl Bioceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Byrl Bioceuticals India has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCN0898H1Z4 | Delhi | Active | 09 Sep 2020 |
To see the full GST registrations and return filing status of Byrl Bioceuticals India Private Limited, buy the company report.
Recent activity
Byrl Bioceuticals India Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Ankur Goyal was appointed as Additional Director on 15 Jun 2022.
AGM
Byrl Bioceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Byrl Bioceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Appointed
Ankur Goyal was appointed as Additional Director.
Appointed
Akanksha Jain was appointed as Additional Director.
Ceased
Priyanka Srivastava ceased to be Director.
Ceased
Sonika Verma ceased to be Director.
Appointed
Priyata Goyal was appointed as Director.
Incorporation
13 Aug 2020
Byrl Bioceuticals India Private Limited was registered on 13 Aug 2020 with Roc Delhi & aged 6 years 3 months as per MCA records.
Frequently asked questions
Byrl Bioceuticals India is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 13 August 2020 (6+ years old) and is registered under CIN U15400DL2020PTC367927.
Byrl Bioceuticals India has 3 current directors:
- Akanksha Jain - Additional Director
- Ankur Goyal - Additional Director
- Priyata Goyal - Director
The latest financial statements of Byrl Bioceuticals India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Byrl Bioceuticals India is 07AAHCN0898H1Z4, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Byrl Bioceuticals India is U15400DL2020PTC367927. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Byrl Bioceuticals India was incorporated on 13 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Byrl Bioceuticals India by revenue are Mechxon Lifecare Private Limited, Clear Imaging Medical Systems Private Limited, Gainwell Medimart Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Ankur Goyal was appointed as Additional Director on 15 Jun 2022. Akanksha Jain was appointed as Additional Director on 02 Jun 2021. Priyanka Srivastava ceased to be Director on 02 Jun 2021. Byrl Bioceuticals India has 5 board changes on record in total.
Yes, Byrl Bioceuticals India is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0001376).
The registered office of Byrl Bioceuticals India is at 702 7th Floor Madhuban Building 55, New Delhi, Delhi, India – 110019.
Byrl Bioceuticals India operates in the healthcare industry, in the medical equipment retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages